Accès ouvert

A Common Pathogenic Founder Variant in Rwandan Breast Cancer Cases

Article scientifique 2026 Autre

Résumé

Abstract Germline data from African populations remain sparse, limiting characterization of population-specific BRCA1 /2 pathogenic variants. In a study of 175 Rwandan women with breast cancer, 7 unrelated carriers (4% of cases; 22% of pathogenic variant carriers) harbored the same BRCA1 frameshift variant, c.4065_4068del (p.Asn1355Lysfs*10), which is extremely rare in gnomAD yet recurrent in European, Asian, and Middle Eastern cohorts. Whole-exome sequencing and haplotype analysis of all 7 carriers revealed a shared ancestral block of approximately 581 kb surrounding the variant, and extended haplotype homozygosity and network analyses confirmed a common founder origin. Coalescent-based age estimation placed the founder event approximately 4,000--10,000 years ago. Comparison with 1000 Genomes Project data showed the founder haplotype is absent or exceedingly rare outside African and South Asian populations. These findings strongly suggest the c.4065_4068del variant as a pre-historical BRCA1 founder variant in Rwanda, with implications for targeted genetic testing, cascade screening, and cancer prevention in the region.

Citer ce document

Manirakiza, A., Baichoo, S., Uwineza, A., Dukundane, D., Rugengamanzi, E., Mutamuliza, J., Niragira, A., Muvunyi, R., Besada, J., Nielsen, S., Bucknor, B., Koeller, D., Andrews, C., Mutesa, L., Fadelu, T., Rebbeck, T. (2026). A Common Pathogenic Founder Variant in Rwandan Breast Cancer Cases. https://doi.org/10.64898/2026.05.26.727861

Accès au document

Texte intégral en lecture en ligne, réservé aux abonnés SPHAERO et aux membres de l'institution. Se connecter

Voir l'article sur le site de la revue

Statistiques

Consultations : 1

Téléchargements : 0